{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:17:53Z","timestamp":1777479473301,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00432-012-1292-1","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T10:25:56Z","timestamp":1343211956000},"page":"2095-2102","source":"Crossref","is-referenced-by-count":23,"title":["Growth inhibitory effect of dihydroartemisinin on Bcr\/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-\u03baB modulation"],"prefix":"10.1007","volume":"138","author":[{"given":"Jun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guobing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"issue":"5","key":"1292_CR1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood.V91.5.1700","volume":"91","author":"GP Amarante-Mendes","year":"1998","unstructured":"Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K (1998) Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 91(5):1700\u20131705","journal-title":"Blood"},{"issue":"1","key":"1292_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1997.56.17","volume":"56","author":"A Benakis","year":"1997","unstructured":"Benakis A, Paris M, Loutan L, Plessas CT, Plessas ST (1997) Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 56(1):17\u201323","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"1292_CR3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","volume":"18","author":"D Cilloni","year":"2012","unstructured":"Cilloni D, Saglio G (2012) Molecular pathways: BCR-ABL. Clin Cancer Res 18(4):930\u2013937. doi: 10.1158\/1078-0432.CCR-10-1613","journal-title":"Clin Cancer Res"},{"issue":"4944","key":"1292_CR4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 247(4944):824\u2013830","journal-title":"Science"},{"issue":"23","key":"1292_CR5","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","volume":"65","author":"GL Disbrow","year":"2005","unstructured":"Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res 65(23):10854\u201310861. doi: 10.1158\/0008-5472.CAN-05-1216","journal-title":"Cancer Res"},{"issue":"7","key":"1292_CR6","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1182\/blood.V91.7.2415","volume":"91","author":"L Dubrez","year":"1998","unstructured":"Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E (1998) BCR-ABL delays apoptosis upstream of procaspase-3 activation. Blood 91(7):2415\u20132422","journal-title":"Blood"},{"issue":"5","key":"1292_CR7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10495-011-0580-6","volume":"16","author":"N Gao","year":"2011","unstructured":"Gao N, Budhraja A, Cheng S, Liu EH, Huang C, Chen J, Yang Z, Chen D, Zhang Z, Shi X (2011) Interruption of the MEK\/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo. Apoptosis 16(5):511\u2013523. doi: 10.1007\/s10495-011-0580-6","journal-title":"Apoptosis"},{"issue":"2","key":"1292_CR8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","volume":"16","author":"LA Hazlehurst","year":"2009","unstructured":"Hazlehurst LA, Bewry NN, Nair RR, Pinilla-Ibarz J (2009) Signaling networks associated with BCR-ABL-dependent transformation. Cancer Control 16(2):100\u2013107","journal-title":"Cancer Control"},{"issue":"10","key":"1292_CR9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4161\/cbt.9.10.11552","volume":"9","author":"Q He","year":"2010","unstructured":"He Q, Shi J, Shen XL, An J, Sun H, Wang L, Hu YJ, Sun Q, Fu LC, Sheikh MS, Huang Y (2010) Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells. Cancer Biol Ther 9(10):819\u2013824","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1292_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00296-009-1218-7","volume":"31","author":"Y He","year":"2011","unstructured":"He Y, Fan J, Lin H, Yang X, Ye Y, Liang L, Zhan Z, Dong X, Sun L, Xu H (2011) The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte. Rheumatol Int 31(1):53\u201360. doi: 10.1007\/s00296-009-1218-7","journal-title":"Rheumatol Int"},{"issue":"2","key":"1292_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/cbt.4.2.1508","volume":"4","author":"Z Jin","year":"2005","unstructured":"Jin Z, El-Deiry WS (2005) Overview of cell death signaling pathways. Cancer Biol Ther 4(2):139\u2013163","journal-title":"Cancer Biol Ther"},{"issue":"17","key":"1292_CR12","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1128\/MCB.22.17.6079-6088.2002","volume":"22","author":"H Kawai","year":"2002","unstructured":"Kawai H, Nie L, Yuan ZM (2002) Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl. Mol Cell Biol 22(17):6079\u20136088","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1292_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00280-005-0002-y","volume":"57","author":"J Lee","year":"2006","unstructured":"Lee J, Zhou HJ, Wu XH (2006) Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemother Pharmacol 57(2):213\u2013220. doi: 10.1007\/s00280-005-0002-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"1292_CR14","doi-asserted-by":"crossref","first-page":"046028","DOI":"10.1117\/1.3481141","volume":"15","author":"YY Lu","year":"2010","unstructured":"Lu YY, Chen TS, Wang XP, Li L (2010) Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques. J Biomed Opt 15(4):046028. doi: 10.1117\/1.3481141","journal-title":"J Biomed Opt"},{"issue":"4946","key":"1292_CR15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"TG Lugo","year":"1990","unstructured":"Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247(4946):1079\u20131082","journal-title":"Science"},{"issue":"3","key":"1292_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.hoc.2004.03.008","volume":"18","author":"JV Melo","year":"2004","unstructured":"Melo JV, Deininger MW (2004) Biology of chronic myelogenous leukemia\u2013signaling pathways of initiation and transformation. Hematol Oncol Clin North Am 18(3):545\u2013568. doi: 10.1016\/j.hoc.2004.03.008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"1292_CR17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cncr.20182","volume":"100","author":"A Panwalkar","year":"2004","unstructured":"Panwalkar A, Verstovsek S, Giles F (2004) Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies. Cancer 100(8):1578\u20131589. doi: 10.1002\/cncr.20182","journal-title":"Cancer"},{"issue":"2","key":"1292_CR18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","volume":"16","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Kantarjian HM, Cortes JE (2009) Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia. Cancer Control 16(2):122\u2013131","journal-title":"Cancer Control"},{"issue":"7","key":"1292_CR19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","volume":"12","author":"JY Reuther","year":"1998","unstructured":"Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr (1998) A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev 12(7):968\u2013981","journal-title":"Genes Dev"},{"issue":"5405","key":"1292_CR20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243(5405):290\u2013293","journal-title":"Nature"},{"issue":"2","key":"1292_CR21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","volume":"86","author":"T Skorski","year":"1995","unstructured":"Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B (1995) Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 86(2):726\u2013736","journal-title":"Blood"},{"issue":"20","key":"1292_CR22","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","volume":"16","author":"T Skorski","year":"1997","unstructured":"Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B (1997) Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway. EMBO J 16(20):6151\u20136161. doi: 10.1093\/emboj\/16.20.6151","journal-title":"EMBO J"},{"issue":"3","key":"1292_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2006.00282.x","volume":"27","author":"M Thomas","year":"2006","unstructured":"Thomas M, Greil J, Heidenreich O (2006) Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials. Acta Pharmacol Sin 27(3):273\u2013281. doi: 10.1111\/j.1745-7254.2006.00282.x","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"1292_CR24","first-page":"976","volume":"112","author":"Y Tu","year":"1999","unstructured":"Tu Y (1999) The development of new antimalarial drugs: qinghaosu and dihydro-qinghaosu. Chin Med J (Engl) 112(11):976\u2013977","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"1292_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2010.01.001","volume":"293","author":"SJ Wang","year":"2010","unstructured":"Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B (2010) Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 293(1):99\u2013108. doi: 10.1016\/j.canlet.2010.01.001","journal-title":"Cancer Lett"},{"issue":"6","key":"1292_CR26","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00280-011-1643-7","volume":"68","author":"SJ Wang","year":"2011","unstructured":"Wang SJ, Sun B, Cheng ZX, Zhou HX, Gao Y, Kong R, Chen H, Jiang HC, Pan SH, Xue DB, Bai XW (2011) Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-kappaB pathway. Cancer Chemother Pharmacol 68(6):1421\u20131430. doi: 10.1007\/s00280-011-1643-7","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-012-1292-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1292-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T11:54:09Z","timestamp":1594468449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-012-1292-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1007\/s00432-012-1292-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}